Gender-Affirming Hormone Therapy Abroad: How to Cross Borders Without a Dosing Gap

Missing a single week of hormone therapy abroad can reverse months of progress. Here is what customs officers, local laws, and supply chains actually mean for your trip.

Gender-affirming hormone therapy abroad: what you need to know

Customs officers do not always know what gender-affirming hormone therapy is, and in some countries the law does not recognise it as a legitimate medical category. That combination creates a specific risk: your medication gets confiscated at the border, not because it is illegal, but because the officer cannot find it in their reference system.

This article focuses on the specific friction points: which countries restrict or complicate access, what documentation actually resolves customs problems, and how to structure your supply so a one-day delay does not become a two-week gap.

Medical disclaimer: This article provides general information only and does not constitute medical or legal advice. Medication regulations and import rules change frequently. Verify current requirements with the relevant embassy, health ministry, or your prescribing clinician before you travel.

What customs officers are actually checking

Most countries permit travellers to carry a personal supply of prescription medication for up to 30 days^[1] without special import permits. Beyond that threshold, you typically need a letter from your prescribing doctor, the original pharmacy packaging, and sometimes a certified translation.

The friction for gender-affirming hormone therapy is not primarily about quantity. It is about the gap between the medication's pharmacological classification and its use case. Testosterone is a controlled substance in most countries because of its anabolic potential in sport. Oestradiol and anti-androgens fall under different schedules depending on the country, with some treating them as standard prescription drugs and others restricting them entirely.

A doctor's letter that names the INN (International Nonproprietary Name) of each medication, states your diagnosis, and confirms the prescribed dose typically resolves most border queries without escalation.

Countries where access is legally restricted or practically unavailable

Several countries have introduced legal restrictions on gender-affirming medical care that extend, in practice, to prescription access for travellers. Russia's federal ban — signed by Putin on 24 July 2023 — outlaws both gender-affirming surgical procedures and hormone therapy when used for gender transition^[2], with the only carve-out being for congenital anomalies (intersex variation) treated in childhood. The law also annuls existing marriages of transgender people and prohibits legal gender marker changes. Carrying GAHT into Russia is not itself a customs offence, but accessing care, refilling prescriptions, or obtaining a bridging supply is now functionally impossible.

The Gulf states present a different risk profile. The UAE, Saudi Arabia, and Qatar do not have specific legislation targeting hormone therapy, but broad laws criminalising gender expression create legal uncertainty around possession of transition-related medication.

In contrast, Thailand, Argentina, Canada, most EU member states, and New Zealand have established clinical frameworks for gender-affirming care, and pharmacy access for travellers with valid prescriptions is generally achievable. Thailand in particular has dedicated gender-affirming clinics in Bangkok and Chiang Mai where travellers can obtain a bridging prescription.

The controlled substance problem with testosterone

Testosterone is a controlled substance in most jurisdictions, including all EU countries, Japan, South Korea, and Australia. Japan regulates testosterone as an anabolic steroid under a separate legal framework from psychotropics, but the practical effect is the same: a Yakkan Shoumei (Yunyu Kakunin-sho) personal-import certificate is required for any prescription supply exceeding one month, applied for at least two to three weeks before travel via the Regional Bureau of Health and Welfare for your airport of arrival. South Korea similarly applies stricter quantity rules for testosterone than for non-controlled hormones.

For testosterone gel, the packaging matters as much as the content. A single large tube that exceeds the one-month equivalent by weight can trigger a controlled-substance check even if your total dose is within the personal allowance.

Anti-androgens such as cyproterone acetate are not available in the United States but are standard prescriptions across Europe and Australia. Spironolactone, the US alternative, may not be stocked in European pharmacies under that name. Carry the generic INN name for every medication you take.

The documentation that actually prevents confiscation

A medication passport or travel letter from your prescribing clinician^[4] should include: your full name, date of birth, the INN name of each medication, the prescribed dose, the total quantity you are carrying, and your prescriber's contact details.

For controlled substances such as testosterone, carry the original pharmacy-labelled packaging. Do not transfer medication into unlabelled containers. The pharmacy label is your primary legal identity document at the border.

If your destination country requires a certified translation, request it from your clinic at least three weeks before departure. Consulate websites for your destination country will specify whether a notarised translation is required.

Structuring your supply to survive delays

The standard advice is to carry a buffer of 10 to 14 days beyond your planned trip. That advice breaks down when your medication is a controlled substance that cannot legally exceed a 30-day total import allowance. In that situation, carry the maximum legal allowance and treat the buffer as part of your planning, not an afterthought.

Split your supply across carry-on and checked luggage only if the controlled substance rules of your destination permit it. For most medications, the carry-on is safer: checked luggage can be lost or delayed, and temperature-sensitive formulations can be damaged in a cargo hold.

If your trip extends beyond the maximum import allowance, identify a prescriber in your destination before you leave. In countries with established gender-affirming care frameworks, such as Argentina, Spain, or Canada, a consultation at a gender clinic can produce a local prescription that covers the remainder of your stay.

Brand names differ across countries

Oestradiol valerate is sold as Progynova in most European countries, as Estrofem in Scandinavia, and under different local brands in Southeast Asia. Testosterone gel is sold as Testogel in Europe and as AndroGel in North America. Knowing the INN for every medication you take means a pharmacist in any country can identify an equivalent, even if your home brand is absent from their shelves. The WHO INN system standardises drug names globally^[5] for exactly this reason.

Bicalutamide is not approved for gender-affirming use in many countries, though it is used off-label. A pharmacist may refuse to dispense it without a specialist referral. Finasteride is widely available without this issue.

Why an International Patient Summary is a practical tool here

The International Patient Summary (IPS) is a structured health record format built on the HL7 FHIR standard. It lists your current medications by INN, your allergies, and your relevant diagnoses in a machine-readable format that clinicians and pharmacists in any country can interpret. HL7 FHIR IPS is now endorsed by the WHO and EU eHealth Network^[6] as the standard for cross-border health data exchange.

For gender-affirming hormone therapy specifically, the IPS provides a clinical record that supplements your doctor's letter. A clinician in an unfamiliar country seeing your medication list can confirm dosing equivalences without having to contact your home prescriber.

Creating your IPS on Nomedic before you travel gives you a portable, structured record that is accessible offline and in any language your destination country's clinicians work in.

Cost of bridging prescriptions abroad

A private consultation at a gender clinic in Bangkok typically costs ฿1,500 to ฿3,000 (~$42 to ~$83 / ~€38 to ~€76). In Buenos Aires, a private endocrinology consultation runs approximately ARS 15,000 to ARS 30,000 (~$17 to ~$34 / ~€15 to ~€31) at current rates. In Spain, a private endocrinologist charges approximately €70 to €120 (~$82 to ~$141) per consultation. EU citizens can access gender-affirming prescriptions through public SNS or equivalents^[7] in most EU member states without paying private rates.

Medication costs vary significantly. In Thailand, a month's supply of oestradiol valerate costs approximately ฿200 to ฿500 (~$6 to ~$14 / ~€5 to ~€13). In Germany, Testogel 50 mg gel costs approximately €30 to €50 (~$35 to ~$59) per month at a private pharmacy without public insurance coverage.

Before you travel: a practical checklist

Confirm your destination's legal status. Check whether your destination country has specific laws restricting gender-affirming medical care or possession of transition-related medications.

Get a doctor's letter with INN names. Ask your prescriber to include the INN, dose, and quantity for every medication. Request a certified translation if your destination requires it.

Carry original pharmacy packaging. Do not repackage controlled substances. The pharmacy label is your primary legal documentation at customs.

Identify a prescriber at your destination before departure. For trips longer than 30 days or to countries with controlled-substance import limits, locate a gender clinic or endocrinologist in advance.

Create your International Patient Summary. Store it on Nomedic so it is accessible offline and can be shared with any clinician regardless of their language or system.

Frequently asked questions

Can I bring testosterone through customs?

Yes, in most countries, provided you carry original pharmacy-labelled packaging and a doctor's letter naming the INN, dose, and quantity. Testosterone is a controlled substance in most jurisdictions, so quantities above a 30-day personal supply typically require additional documentation or import permits.

Which countries should transgender travellers avoid?

Russia criminalised gender transition procedures in 2023, creating legal risk for travellers carrying transition-related medications. The Gulf states, including the UAE and Saudi Arabia, have broad laws around gender expression that create legal uncertainty. Check the travel advisory from your country's foreign ministry before travelling to any destination with restrictive laws.

What if my medication brand is not available at my destination?

Ask your pharmacist for the INN (International Nonproprietary Name) of each medication you take. Any pharmacist globally can use the INN to identify a local equivalent. Oestradiol valerate, testosterone gel, and bicalutamide are all available under different brand names depending on the country.

Can I get a bridging prescription abroad if my supply runs out?

In countries with established gender-affirming care, such as Thailand, Argentina, Spain, and Canada, a consultation at a gender clinic or endocrinologist can produce a local prescription. Costs range from approximately ฿1,500 (~$42 / ~€38) in Thailand to €70 (~$82) or more in Western Europe. Identify a local prescriber before your trip, not after your medication runs out.

Does cyproterone acetate cause problems at customs?

Cyproterone acetate is a prescription medication not approved in the United States, so travellers carrying it into the US may encounter unfamiliarity from customs officers. Carry a doctor's letter with the INN and your diagnosis. It is a standard prescription in most EU countries, Australia, and Thailand.

What is an International Patient Summary and why does it help?

An International Patient Summary (IPS) is a structured digital health record built on the HL7 FHIR standard. It lists your medications by INN, allergies, and diagnoses in a format any clinician globally can read. It complements your doctor's travel letter and is particularly useful when seeking emergency or bridging care abroad.